ROCKET PHARMACEUTICALS
Rocket Pharmaceuticals is an emerging biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. The Company’s lead program is a lentiviral-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. Preclinical studies of additional bone marrow-derived disorders are ongoing and target Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-1 (LAD-1) and Infantile Malignant Osteopetrosis. The Company is also developing an AAV-based gene therapy program for an undisclosed rare pediatric disease.
ROCKET PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Grand Cayman, Midland, Cayman Islands
Country:
Cayman Islands
Website Url:
http://www.rocketpharma.com
Total Employee:
11+
Status:
Active
Contact:
646-224-9585
Email Addresses:
[email protected]
Total Funding:
552.76 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-09-12 | Inotek Pharmaceuticals | Inotek Pharmaceuticals acquired by Rocket Pharmaceuticals | N/A |
Investors List
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - Rocket Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Rocket Pharmaceuticals
California Institute of Regenerative Medicine (CIRM)
California Institute of Regenerative Medicine (CIRM) investment in Grant - Rocket Pharmaceuticals
California Institute of Regenerative Medicine (CIRM)
California Institute of Regenerative Medicine (CIRM) investment in Grant - Rocket Pharmaceuticals
Sahsen Ventures
Sahsen Ventures investment in Post-IPO Equity - Rocket Pharmaceuticals
Civilization Ventures
Civilization Ventures investment in Post-IPO Equity - Rocket Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.rocketpharma.com Semrush global rank: 3.69 M Semrush visits lastest month: 3.78 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rocket Pharmaceuticals"
Home | Rocket Pharmaceuticals
Our mission is to seek gene therapy cures for patients with devastating rare diseases through the most innovative science and platforms to fulfill the promise of gene therapy for the betterment …See details»
About Us | Rocket Pharmaceuticals
Our mission is to seek gene therapy cures for patients with devastating rare diseases through the most innovative science and platforms to fulfill the promise of gene therapy for the betterment of our industry, science and humanity. Our …See details»
Board of Directors - Rocket Pharmaceuticals, Inc.
Mr. Woods is a seasoned executive with more than 30 years of industry experience who most recently served as Chief Operating Officer of argenx, where he led its global commercial …See details»
Rocket Pharmaceuticals - Crunchbase Company Profile & Funding
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders. Rocket Pharmaceuticals may be growing as indicated by a shift from …See details»
Rocket Pharmaceuticals - LinkedIn
Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company seeking gene therapy cures. Rocket places enormous value on people and takes team member progress and well-being just...See details»
Rocket Pharmaceuticals to Participate in the 7th Annual Evercore ...
2 days ago · CRANBURY, N.J.--(BUSINESS WIRE)--Nov. 26, 2024-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a …See details»
News Release Details - ir.rocketpharma.com
CRANBURY, N.J. -- (BUSINESS WIRE)--Nov. 7, 2024-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline …See details»
Overview, News & Similar companies - ZoomInfo.com
May 7, 2024 · Rocket Pharmaceuticals contact info: Phone number: (646) 440-9100 Website: www.rocketpharma.com What does Rocket Pharmaceuticals do? Rocket Pharmaceuticals, …See details»
Rocket Pharmaceuticals CEO and Key Executive Team | Craft.co
Rocket Pharmaceuticals's key executives include Roderick Wong and 14 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on …See details»
Patients & Caregivers | Rocket Pharmaceuticals
We encourage you to explore more about the following organizations that offer resources and information for patients and caregivers. If your group would like to be included in our list of patient resources, please reach out to us at …See details»
Rocket Pharmaceuticals - Craft
Oct 29, 2024 · Rocket Pharmaceuticals is a biotechnology company focused on seeking cures through molecular and gene therapy. It develops treatments for patients with rare and often …See details»
Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase …
Sep 12, 2023 · Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is advancing an integrated and sustainable pipeline of investigational genetic therapies designed to correct the root cause of …See details»
Working at Rocket Pharma - Glassdoor
Make a difference in patients' lives one submission at a time! Rocket's Regulatory organization provides unmatched expertise related to global regulatory activities through all stages of a …See details»
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 ...
Feb 26, 2024 · Advancing leading pipeline of six disclosed programs across AAV cardiovascular and LV hematology portfolios; all milestones remain on track for 2024. Expanding commercial …See details»
Our Science | Rocket Pharmaceuticals
In close partnership with patient, medical and scientific communities, Rocket is harnessing cutting-edge science and innovation to correct diseases at the genetic level to enable people to live …See details»
How Rocket Pharma quietly became one of gene therapy’s high …
Mar 11, 2021 · Even so, Rocket has quietly become one of the most valuable gene therapy developers that are still independent, worth more than well-established companies like …See details»
Our Disease Focus | Rocket Pharmaceuticals
Provide patient-centric data for health authorities such as the FDA, and other public health institutions to use in their review processes of investigational treatments. At Rocket, we are in …See details»
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2021 ...
Feb 24, 2022 · CRANBURY, N.J. -- (BUSINESS WIRE)--Feb. 24, 2022-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable …See details»
Rocket Pharmaceuticals Reports Full Year 2019 Financial Results …
NEW YORK -- (BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic …See details»
Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI ...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of investigational genetic therapies designed to …See details»